Quadrivalent Inactivated Influenza Vaccine

Phase 1Vaccine

Quadrivalent Inactivated Influenza Vaccine is one of 4 biologic programs targeting Clinical Stage I Cutaneous Melanoma AJCC v8. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Clinical Stage I Cutaneous Melanoma AJCC V8Recruiting

Clinical Stage I Cutaneous Melanoma AJCC V8Phase 1

Recruiting

Competition

Competitive Landscape

3 competitors in Clinical Stage I Cutaneous Melanoma AJCC V8

#DrugCompanyPhaseTrials

Yervoy

Bristol-Myers Squibb

Phase 1

1 2

Opdivo

Bristol-Myers Squibb

Phase 1

1 3

Keytruda

Merck & Co.

Phase 1

1 4

Quadrivalent Inactivated Influenza Vaccine

Sanofi

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Phase 1Recruiting

Clinical Stage I Cutaneous Melanoma AJCC V8

NCT04697576

Clinical

Trials by Indication[1]

Influenza6 trials

Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya

Withdrawn·CCenters for Disease Control and Prevention·Phase 2/3·NCT01810731

Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South Korea

Completed· Sanofi logo

Sanofi·Phase 3·NCT05144945·301 enrolled

Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers.

Completed·OOsivax·Phase 2·NCT05284799·180 enrolled

Show 3 more trials

Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)

Completed·SStanford University·Phase 4·NCT01827462·136 enrolled

Response to Influenza Vaccine During Pregnancy

Terminated·SStanford University·Phase 1·NCT03888989·2 enrolled

Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood

Withdrawn·SStanford University·Phase 4·NCT03898973

Pregnant Women1 trial

Safety of RIV4 Versus IIV4 in Pregnant Women

Completed·—·Phase 4·NCT03969641·384 enrolled

Transplant Recipient1 trial

High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients

Completed·VVanderbilt-Ingram Cancer Center·Phase 2·NCT03179761·124 enrolled

Clinical Stage I Cutaneous Melanoma AJCC v81 trial

Intralesional Influenza Vaccine for Patients With Melanoma

Recruiting·CCarlo Contreras·Phase 1·NCT04697576·36 enrolled

Sources

References

[1]
ClinicalTrials.gov — 9 trial records for Quadrivalent Inactivated Influenza Vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Quadrivalent Inactivated Influenza Vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Quadrivalent Inactivated Influenza Vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sanofi company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Phase 1[1]
Company: Sanofi

Quadrivalent Inactivated Influenza Vaccine

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Influenza6 trials

Pregnant Women1 trial

Transplant Recipient1 trial

Clinical Stage I Cutaneous Melanoma AJCC v81 trial

References

Drug Info

Quick Facts

Related News